Oncocyte Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stock Analysts’ price target changes for Monday, November 13th: ProFrac (NASDAQ:ACDC) had its price target cut by Piper Sandler from $16.00 to $14.00. Piper Sandler currently has an overweight rating on the stock. Adaptive Biotechnologies (NASDAQ:ADPT) had its price target trimmed by Piper Sandler from $13.00 to $6.00. The firm currently has an overweight rating […]

Equities Research Analysts’ updated eps estimates for Friday, July 7th: Air Canada (TSE:AC) had its outperform rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a C$31.00 price target on the stock. Associated Capital Group (NYSE:AC) had its outperform rating reissued by analysts at Scotiabank. Scotiabank currently has a $31.00 target price on the stock. […]

OncoCyte Co. (NASDAQ:OCX – Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 1,070,000 shares, a decline of 24.6% from the May 31st total of 1,420,000 shares. Based on an average daily volume of 335,500 shares, the short-interest ratio is presently […]

OncoCyte Co. (NASDAQ:OCX – Free Report) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 1,070,000 shares, a decline of 24.6% from the May 31st total of 1,420,000 shares. Based on an average daily volume of 335,500 shares, the days-to-cover ratio is currently […]

Stock Analysts’ updated eps estimates for Sunday, July 2nd: Coats Group (OTCMKTS:CGGGF) had its target price cut by Jefferies Financial Group Inc. from GBX 102 ($1.30) to GBX 97 ($1.23). 89bio (NASDAQ:ETNB) had its target price raised by BTIG Research from $30.00 to $37.00. Interpublic Group of Companies (NYSE:IPG) had its price target boosted by […]